Sage Therapeutics Statistics
Total Valuation
Ameren has a market cap or net worth of $27.61 billion. The enterprise value is $47.58 billion.
Important Dates
The last earnings date was Thursday, July 31, 2025, after market close.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Jun 10, 2025 |
Share Statistics
Ameren has 270.40 million shares outstanding. The number of shares has increased by 1.72% in one year.
| Current Share Class | 270.40M |
| Shares Outstanding | 270.40M |
| Shares Change (YoY) | +1.72% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 82.28% |
| Float | 269.08M |
Valuation Ratios
The trailing PE ratio is 22.46 and the forward PE ratio is 20.06. Ameren's PEG ratio is 2.62.
| PE Ratio | 22.46 |
| Forward PE | 20.06 |
| PS Ratio | 3.37 |
| Forward PS | 3.17 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 9.18 |
| PEG Ratio | 2.62 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 38.78 |
| EV / Sales | 5.85 |
| EV / EBITDA | 14.31 |
| EV / EBIT | 24.67 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.61.
| Current Ratio | 0.80 |
| Quick Ratio | 0.37 |
| Debt / Equity | 1.61 |
| Debt / EBITDA | 6.01 |
| Debt / FCF | n/a |
| Interest Coverage | 2.73 |
Financial Efficiency
Return on equity (ROE) is 10.22% and return on invested capital (ROIC) is 3.90%.
| Return on Equity (ROE) | 10.22% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 3.90% |
| Return on Capital Employed (ROCE) | 4.43% |
| Revenue Per Employee | $905,578 |
| Profits Per Employee | $136,622 |
| Employee Count | 8,981 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 5.88 |
Taxes
In the past 12 months, Ameren has paid $93.00 million in taxes.
| Income Tax | 93.00M |
| Effective Tax Rate | 7.02% |
Stock Price Statistics
The stock price has increased by +28.81% in the last 52 weeks. The beta is 0.46, so Ameren's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +28.81% |
| 50-Day Moving Average | 96.84 |
| 200-Day Moving Average | 94.99 |
| Relative Strength Index (RSI) | 68.19 |
| Average Volume (20 Days) | 1,579,143 |
Short Selling Information
The latest short interest is 9.83 million, so 3.63% of the outstanding shares have been sold short.
| Short Interest | 9.83M |
| Short Previous Month | 8.81M |
| Short % of Shares Out | 3.63% |
| Short % of Float | 3.65% |
| Short Ratio (days to cover) | 5.87 |
Income Statement
In the last 12 months, Ameren had revenue of $8.13 billion and earned $1.23 billion in profits. Earnings per share was $4.55.
| Revenue | 8.13B |
| Gross Profit | 3.79B |
| Operating Income | 1.93B |
| Pretax Income | 1.36B |
| Net Income | 1.23B |
| EBITDA | 3.33B |
| EBIT | 1.93B |
| Earnings Per Share (EPS) | $4.55 |
Full Income StatementBalance Sheet
The company has $11.00 million in cash and $19.98 billion in debt, giving a net cash position of -$19.97 billion or -$73.85 per share.
| Cash & Cash Equivalents | 11.00M |
| Total Debt | 19.98B |
| Net Cash | -19.97B |
| Net Cash Per Share | -$73.85 |
| Equity (Book Value) | 12.44B |
| Book Value Per Share | 45.54 |
| Working Capital | -613.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.01 billion and capital expenditures -$4.63 billion, giving a free cash flow of -$1.62 billion.
| Operating Cash Flow | 3.01B |
| Capital Expenditures | -4.63B |
| Free Cash Flow | -1.62B |
| FCF Per Share | -$6.00 |
Full Cash Flow StatementMargins
Gross margin is 46.56%, with operating and profit margins of 23.72% and 15.09%.
| Gross Margin | 46.56% |
| Operating Margin | 23.72% |
| Pretax Margin | 16.29% |
| Profit Margin | 15.09% |
| EBITDA Margin | 40.88% |
| EBIT Margin | 23.72% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $2.84, which amounts to a dividend yield of 2.78%.
| Dividend Per Share | $2.84 |
| Dividend Yield | 2.78% |
| Dividend Growth (YoY) | 6.15% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 60.71% |
| Buyback Yield | -1.72% |
| Shareholder Yield | 1.09% |
| Earnings Yield | 4.44% |
| FCF Yield | -5.88% |
Dividend DetailsAnalyst Forecast
The average price target for Ameren is $102.82, which is 0.70% higher than the current price. The consensus rating is "Buy".
| Price Target | $102.82 |
| Price Target Difference | 0.70% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 7.83% |
| EPS Growth Forecast (5Y) | 8.89% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
